Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation
Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation
Not yet recruiting · NCT06640738 · Registry updated 2024-10-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, leiomyoma, myomatous neoplasm, neoplasm | Not yet recruiting | Phase 4 | 2024-10-15 | NCT06640738 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kaohsiung Medical University | 21 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||